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Background: Neurological conditions or disorders strike 
roughly 50 million Americans annually but accurate and 
comprehensive national estimates for many of these conditions 
are not available. In 2019, Congress provided $5 million to 
Centers for Disease Control and Prevention (CDC) to establish 
the National Neurological Conditions Surveillance System 
(NNCSS). CDC focused initial activities on multiple sclerosis 
and Parkinson’s disease. 
 
Purpose: We conducted a process evaluation to document and 
understand multifaceted work to implement a new surveillance 
activity for two neurological conditions. 
 
Setting: We conducted this evaluation with government 
personnel internal to the Center for Surveillance, 
Epidemiology, and Laboratory Services at the Centers for 
Disease Control and Prevention in Atlanta, GA. 
 
Intervention: A new public health surveillance activity for two 
neurological conditions, multiple sclerosis and Parkinson’s 
disease, that uses existing data resources and systems. 
 
Research design: The evaluation included interviews with CDC 
personnel and review of administrative and programmatic 
information. Data were analyzed and interpreted to identify 
crucial moments in the first year of funded work on NNCSS. 
The study revealed that this surveillance activity required 
diverse contributions and collaboration within the federal 
government and with non-governmental organizations. The 
findings can be used to guide work to enhance surveillance for 
many neurological conditions. 
 
Findings: The study revealed that this surveillance activity 
required diverse contributions and collaboration within the 
federal government and with non-governmental 
organizations. While collaboration is a cornerstone of public 
health practice, it is not always well-documented in planning 
or implementation of surveillance or other data-related 
activities. 
Keywords: program evaluation; surveillance; neurological conditions; neurological disorders; multiple sclerosis; Parkinson’s 
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Neurological conditions or disorders touch the 
lives of millions of Americans and cost 
hundreds of billions of dollars in medical 
expenses and lost productivity (National 
Institute of Neurological Disorders and Stroke, 
2019). Yet, we do not have accurate and 
comprehensive information on incidence or 
prevalence for many of these conditions 
(Pringsheim et al., 2014). This lack of 
information can hinder attention to the 
conditions and remains a concern among 
patients, their families, and advocacy 
organizations. In 2016, as part of the 21st 
Century Cures Act (2016), Congress 
authorized the U.S. Centers for Disease 
Control and Prevention (CDC) to develop a 
National Neurological Conditions Surveillance 
System (NNCSS). In Fiscal Year 2019, 
Congress provided $5 million to CDC to 
support work on this new surveillance activity. 
As a starting point, CDC (2020a) aimed to 
understand the interests and needs of diverse 
stakeholders; identify and assess potential 
data sources and analytic methods; produce 
national estimates of prevalence and incidence 
for multiple sclerosis (MS) and Parkinson’s 
disease (PD); and capture lessons learned that 
can be used to enhance surveillance for these 
and other neurological conditions. In the 
NNCSS logic model, additional outcomes of the 
work included robust and ongoing 
collaboration among government and non-
government organizations and expanded use 
of existing, internal data resources to support 
surveillance for neurologic conditions (CDC, 
2020b). For example, CDC Data Hub provides 
centralized acquisition of external health care 
data for programs agency-wide (Division of 
Health Informatics and Surveillance, 2019). 
Personnel used this enterprise-level, shared 
resource to access a range of data relevant to 
MS and PD. No primary data collection or new 
information technology-based system was 
needed to develop this surveillance activity. 
CDC-based stakeholders viewed work on 
NNCSS as an opportunity to contribute to 
cross-functional collaboration under the 
Public Health Surveillance Strategy (CDC, 
2018). We used process evaluation to 
document and understand a full complement 
of activities in the first year of funded work. 
Information from this evaluation was used to 
improve current work on national estimates of 
incidence and prevalence for MS and PD and 
can be used to support future work on 
surveillance for other neurological conditions. 
 
Data Collection, Analysis, and 
Interpretation 
 
Program evaluation refers to “the systematic 
collection of information about the activities, 
characteristics, and results of programs to 
make judgments about the program, improve 
or further develop program effectiveness, 
inform decisions about future programming, 
and/or [sic] increase understanding” (Patton, 
2008, p.39). In this case, we used process 
evaluation to examine what was included in 
initial work on this surveillance activity and 
how it occurred over time (CDC, 2008). 
Process evaluations provide information on 
the implementation of an activity or program 
and can address how resources were used and 
roles and participation across contributors or 
other stakeholders, for example (Limbani et 
al., 2019; Moore et al., 2015). This evaluation 
addressed two questions: (1) how did 
contributors establish surveillance for two 
neurological conditions, and (2) what can be 
learned from this work that can be used to 
improve surveillance for these and other 
neurological conditions? Data collection 
methods to address these questions included 
key informant interviews with personnel in the 
Center for Surveillance, Epidemiology, and 
Laboratory Services at the CDC and review of 
administrative and operational documents 
internal to CDC and on a public-facing 
webpage. Eleven participants explained their 
work on this surveillance activity in eight, one-
hour interviews. For example, they discussed 
individual roles and responsibilities, practical 
challenges in their work on this activity, and 
decisions made in language understandable 
by someone unfamiliar with public health 
practice or surveillance, specifically. The 
information was captured in notes and 
analyzed to create a single list of twenty-eight 
decisions and tasks articulated by 
interviewees as important aspects of the work 
process. The list included the specific items 
that participants identified as necessary to 
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stand up this new surveillance activity. In 
many cases, interviewees talked about the 
same activities or tasks from different 
perspectives. A subset of interviewees 
reviewed this list to validate the information. 
Review of the program description, logic 
model, and work plans did not produce 
additions to the list but aided in 
understanding the order of items and any 
interrelationships between or among items. 
While each contribution was important, this 
evaluation aimed to document and 
understand decisions and tasks seen as 
crucial to early progress to establish 
surveillance for MS and PD. This information 
can be used to enhance continued work on 
surveillance for these conditions and support 
work to initiate or improve surveillance for 
other neurological conditions. 
Personnel identified discrete criteria to 
determine whether a decision or task that 
surfaced via this evaluation represented a 
crucial moment in the first year of funding for 
NNCSS activities. Crucial moments were 
defined as essential junctures where CDC 
personnel and stakeholders made decisions, 
set a direction, or took action. Specifically, 
decisions or tasks interpreted as crucial 
moments met six criteria: aligned to content in 
the public-facing logic model; were understood 
as high-stakes items; addressed a 
commitment or mandate of some sort; were a 
culminating action, decision, event, or 
product; improved the credibility, 
transparency, or visibility of this surveillance 
activity; or required all, or nearly all, work 
streams to implement the item. For example, 
each decision or task interpreted as crucial 
can be mapped to specific content in the 
NNCSS logic model. Decisions or tasks were 
viewed as high stakes when, if not done, a 
process or product could be delayed, fail 
entirely, or create a risk to resources or 
progress toward intended outcomes. The 
criterion that addressed a commitment or 
mandate to undertake an item included 
requirements in Congressional language, 
expectations articulated by Department of 
Health and Human Services or CDC 
leadership, a cooperative agreement or 
contract that specifies the work, or 
agreements with other stakeholders. Items 
that represented key milestones in the project 
and required substantial collaboration across 
work streams were also considered crucial. 
Finally, decisions or tasks seen as vital to 
improve the credibility, transparency, or 
visibility of this surveillance activity among 
stakeholders (internal or external to the 




This evaluation produced detailed information 
on multiple streams of work in the first year of 
funding for the NNCSS. Specifically, the in-
depth interviews and review of principal 
documents produced a series of twenty-eight 
decisions and tasks relevant to administrative 
and planning functions, collaboration 
(internal and external to the agency), 
communications, data sources and analytics, 
leadership and management, legislative and 
policy activities, program evaluation, and 
science-related activities to fully understand 
MS and PD as a foundation to many aspects 
of this surveillance activity. From the twenty-
eight decisions and tasks articulated as 
important aspects of the work process, we 
identified fifteen crucial moments via 
application of the six criteria discussed 
previously. The decisions and tasks identified 
as crucial moments met all six of these 
criteria. In Figure 1, we visualize the crucial 
moments in an annotated timeline in plain 
language. For each crucial moment in Figure 
1, there is a brief description of the decision or 
task, associated dates, and whether the item 
is ongoing. Current and future staff and 
stakeholders can use the information to 
understand initial activities and 
accomplishments to develop this surveillance 
activity. The crucial moments summarize what 
was done, how, and when. For example, the 
annotated timeline reveals that work to initiate 
this public health surveillance activity was 
interdisciplinary; it was not done solely by 
epidemiologists or subject matter experts in a 
specific condition or disorder. We also see that 
only five of the fifteen crucial moments 
presented in Figure 1 focus entirely on data-
related activities or tasks. Most crucial 
moments depict a coalition of diverse, 
multidisciplinary contributors, internal and 
external to the agency. For example, several 
crucial moments include communications 
work: internal communications, 
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communications with stakeholders external to 
the agency, and communication materials or 





Figure 1. Annotated timeline of crucial moments to establish the national neurological conditions 
surveillance system (October 1, 2018 - December 31, 2019) 
October 1, 2018
Congress appropriates funds for the National Neurological 
Conditions Surveillance System (NNCSS)
October 22, 2018 (ongoing)
CDC launches a public-facing webpage for the 
NNCSS that includes a project description, key 
resources, and frequently asked questions. CDC 
will add items to the page as work continues. 
May 31, 2019
CDC releases a logic model for this surveillance activity 
on the public-facing webpage for the NNCSS. The 
graphic and accompanying narrative depict and explain 
activities and intended outcomes in Fiscal Year 2019. 
November 6, 2018
CDC allocates funds to support personnel, contract 
services, data purchases, a cooperative agreement, 
an interagency agreement, and travel costs.
November 15, 2019 (ongoing)
CDC completes initial weighting of population data and 
calculates population-speci!c estimates of prevalence for 
MS and PD using two data sources: Medicaid and Medicare 
claims and PharMetrics PlusTM commercial claims.
February 6, 2019 (ongoing)
CDC establishes a Surveillance Science Working Group 
to examine methodological issues to support work on 
NNCSS. Participants include CDC personnel with expertise 
in surveillance, data science, and neuroepidemiology; and 
neurologists and neuroscientists with expertise in MS and 
PD from the National Institute of Neurological Disorders and 
Stroke (NINDS) at the National Institutes of Health (NIH).
March 20, 2019
CDC personnel meet with representatives of NINDS 
at NIH to explore opportunities to collaborate to 
support current and future work on NNCSS. 
March 30, 2019 (ongoing)
CDC proposes initial case identi!cation algorithms 
for MS and PD surveillance. These algorithms were 
re!ned to match clinical guidelines and vetted with 
external subject matter experts and the SSWG.
October 2, 2018
The U.S. Centers for Disease Control and Prevention (CDC) 
proposes a strategy to establish the NNCSS that includes an initial 
focus on multiple sclerosis (MS) and Parkinson’s disease (PD). The 
demonstration project aimed to estimate incidence and prevalence 
for these conditions and develop approaches and methods that can 
be used to support surveillance for other neurological conditions.
October 29, 2018
CDC personnel meet with Michael J. Fox Foundation 
(MJFF) and National Multiple Sclerosis Society (NMSS) 
representatives to initiate collaboration on year one activities.
November 5, 2019
The Association of State and Territorial Health Officials and 
CDC host the Neurological Conditions Surveillance Summit 
in Atlanta, GA. The event included representatives of 25 
non-governmental organizations that work on neurological 
conditions and key personnel from programs across CDC. 
November 28, 2018 (ongoing)
CDC establishes a multidisciplinary workgroup to plan 
and implement NNCSS activities. The group meets 
weekly and includes personnel from the Center for 
Surveillance, Epidemiology, and Laboratory Services.
March 6, 2019 (ongoing)
CDC personnel assess potential data sources, traditional 
and non-traditional, that can be used to estimate incidence 
and prevalence for MS and PD. For example, personnel 
reviewed existing publications, algorithms for case 
identi!cation, and needs for population-speci!c estimates.
March 21-22, 2019
CDC hosts a meeting with representatives of the U.S. 
Department of Health and Human Services, U.S. Department 
of Veteran’s Affairs, NIH, Parkinson’s Foundation, MJFF, and 
NMSS. CDC personnel share information on planning and 
participants explore opportunities for collaboration. 
April 20, 2019
CDC develops preliminary, unweighted estimates of 
prevalence for MS and PD. At this time, the data sources 
used included Medicaid and Medicare claims, and 
MarketScan® and PharMetrics PlusTM commercial claims. 






This evaluation aimed to document activities 
to establish a model surveillance approach 
with an initial focus on two neurological 
conditions. We used process evaluation to 
identify and understand a series of crucial 
moments in funded work for a fifteen-month 
period. The series of crucial moments 
presented in this practice brief represent real-
world, tangible junctures where CDC 
personnel and stakeholders made decisions, 
set a direction, or took action. Looking more 
closely, each of these moments is marked by 
collaboration, internal or external to the 
agency. Certainly, collaboration is widely 
accepted as necessary to effective program 
implementation in public health (Frieden, 
2014). Yet, collaboration it is not always well-
documented in relation to planning or 
implementation of public health surveillance 
or other data-related activities. The evaluation 
revealed that initial work on NNCSS included 
diverse contributions in addition to the 
epidemiological expertise common to public 
health surveillance activities. 
While the annotated timeline presents 
crucial moments in sequential order beginning 
in October 2018, it does not explain the 
substantial work that occurred prior to 
legislative action to establish the NNCSS and 
support the activity. Similarly, the annotated 
timeline presents the crucial moments in a 
level of detail that does not include the daily or 
weekly work needed to complete or produce 
each crucial moment. Nonetheless, the 
consistency aids readers to understand the 
overall progression of early work on NNCSS 
and provides a window into a collaborative, 
multidisciplinary public health surveillance 
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